Lantern Pharma Inc. · NASDAQ:LTRN
Schalop Lee Troy bought 48,544 Lantern Pharma Inc. shares (Form 4)
Traded May 12, 2026 · Filed May 14, 2026
On May 12, 2026, Schalop Lee Troy (Director) bought 48,544 Lantern Pharma Inc. shares at US$2.06 for US$100K, leaving 48,544 shares. Filed May 14, 2026 (Form 4).
- Bought
- 48,544 shares
- Price
- US$2.06
- Value
- US$100K
- Holding after
- 48,544 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 12, 2026 | Common stock, $0.001 par value | Buy | 48,544 | US$2.06 | 48,544 | Direct |
Source
Related
- Lantern Pharma Inc.
- Schalop Lee Troy
- Lantern Pharma Inc. shareholders
- Schedule 13G/A · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · Empery Asset Management, LP · Aug 4, 2026
- Schedule 13G/A · Thomas A. Satterfield, Jr. · Jul 23, 2026
- Schedule 13D/A · BIOS Advisors GP, LLC · May 15, 2026
- Form 4 · Keyser D Jeffrey · May 14, 2026